Top Story
HEORThe ISPOR 2024 conference, a key event for Health Economics and Outcomes Research (HEOR), will take place from May 5th to 8th in Atlanta, Georgia. This global gathering, of which is expected to draw nearly 5000 participants, will explore the theme "HEOR: A Transformative Force for [...]
Latest Stories
Featured Webinars
Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
Thursday, May 23, 2024
Sponsor: OM1
Insights from the 2024 Salary Survey Report by HealthEconomics.com
Wednesday, May 1, 2024
Webinar Host: Scientist.com
The live session will focus on the latest salary and bonus trends for professionals in the field, including a comprehensive overview [...]
Beyond Accelerated Approvals: External Control Arms
Wednesday, April 10, 2024
Sponsor: Cardinal Health
Delphi Panels: What Are They Good For?
Tuesday, March 12, 2024
Sponsor: Partnership for Health Analytic Research (PHAR)
Handpicked Promotions & Highlights
Latest in Catalyst News powered by BioPharmCatalyst
04/23/2024 04:45 PM ET
Zevra Therapeutics ZVRA date announcement
Zevra Therapeutics already had three catalyst announcements coming up, but they added another one today. On June 30, 2024, it will announce top-line results for their recent Phase 1 trial for KP1077. Our calculations show [...]
Read More
04/23/2024 04:45 PM ET
YS Biopharma Co. Ltd. YS date announcement
Now that the Phase 2/3 trial of PIKA Recombinant COVID-19 Vaccine is completed, YS Biopharma Co. Ltd. will announce their top-line results on June 30, 2024. Our predictive system gives the drug a 46% chance [...]
Read More
04/23/2024 04:45 PM ET
ABVC BioPharma TNXP date announcement
After specifying an announcement date for TNX-102 SL - (PREVAIL) trial results, Tonix Pharmaceuticals Holding now has three catalyst announcements planned. On June 30, 2024, Tonix Pharmaceuticals Holding will announce top-line results for their recent [...]
Read More
04/23/2024 04:45 PM ET
Abeona Therapeutics PPBT date announcement
Now that the Phase 1/2 trial of NT-219 is completed, Purple Biotech Ltd. will announce their top-line results on June 30, 2024. Our calculations show a 60.9% chance that the drug makes it to the [...]
Read MoreSearch HealthEconomics.com
Throw in a keyword, research topic, disease model or technology of interest
